CANB Can B Corp

USD 0.01 0.00 0
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.01

0.00 (0.00)%

USD 0.49M

0.11M

N/A

N/A

Icon

CANB

Can B Corp (USD)
COMMON STOCK | NSD
USD 0.01
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.49M

N/A

USD 0.01

Can B Corp (CANB) Stock Forecast

N/A

Based on the Can B Corp stock forecast from 0 analysts, the average analyst target price for Can B Corp is not available over the next 12 months. Can B Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Can B Corp is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Can B Corp’s stock price was USD 0.008999999999999999. Can B Corp’s stock price has changed by -25.00% over the past week, -44.44% over the past month and -96.68% over the last year.

No recent analyst target price found for Can B Corp
No recent average analyst rating found for Can B Corp

Company Overview Can B Corp

Can B Corp. develops, manufactures, and sells hemp biomass derived products containing cannabinoids. The company provides hemp cannabinoid products, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products ...Read More

https://canbcorp.com

960 South Broadway, Hicksville, NY, United States, 11801

12

December

USD

USA

Adjusted Closing Price for Can B Corp (CANB)

Loading...

Unadjusted Closing Price for Can B Corp (CANB)

Loading...

Share Trading Volume for Can B Corp Shares

Loading...

Compare Performance of Can B Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for CANB

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Can B Corp (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NBIX
Neurocrine Biosciences Inc 0.00 (0.00%) USD14.84B 39.95 36.15

ETFs Containing CANB

Symbol Name CANB's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Can B Corp (CANB) Stock

Stock Target Advisor's fundamental analysis for Can B Corp's stock is Bearish.

Unfortunately we do not have enough data on CANB's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on CANB's stock to indicate what its average analyst target is.

CANB stock's Price/Earning ratio is 15.25. Our analysis grades CANB stock's Price / Earning ratio at F. This means that CANB stock's Price/Earning ratio is above 49% of the stocks in the Drug Manufacturers - Specialty & Generic sector in the NSD exchange. Based on this CANB may be fairly valued for its sector

The last closing price of CANB's stock was USD 0.01.

The most recent market capitalization for CANB is USD 0.49M.

Unfortunately we do not have enough analyst data on CANB's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Can B Corp's stock.

As per our most recent records Can B Corp has 12 Employees.

Can B Corp's registered address is 960 South Broadway, Hicksville, NY, United States, 11801. You can get more information about it from Can B Corp's website at https://canbcorp.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...